Polku Therapeutics

Polku Therapeutics Oy

This company develops small molecule therapies targeting neurodegenerative diseases for patients with conditions such as dementia, Parkinson's and traumatic brain injury.

Polku Therapeutics Oy

This company develops small molecule therapies targeting neurodegenerative diseases for patients with conditions including Alzheimer's, Parkinson's and progressive supranuclear palsy.

Muna Therapeutics

This biopharmaceutical company develops small-molecule therapeutics to treat neurodegenerative diseases, such as Alzheimer's and Parkinson's, for patients and healthcare providers.

Violet Therapeutics

This company develops small molecule inhibitors for pharmaceutical researchers to treat neurodegenerative diseases, including Alzheimer’s and Parkinson’s.

NeurOdys Therapeutics

This biotechnology company develops small molecule therapies for patients with neurodegenerative conditions such as Alzheimer's and Parkinson's diseases.

CuraSen Therapeutics

This biopharmaceutical company develops small molecule drugs to treat patients with neurodegenerative disorders, such as Parkinson's and Alzheimer's disease.

Yumanity Therapeutics

This company develops small molecule drugs to treat neurodegenerative diseases for patients with conditions such as Parkinson's disease and amyotrophic lateral sclerosis.

Vanqua Bio

This biopharmaceutical firm develops small-molecule therapies for patients with neurodegenerative conditions including Parkinson's disease, Alzheimer's and Gaucher disease.